Technology ID
E-321-2013-0

Immunoassays and Methods to Diagnose Syphilis by Immobilizing a Lipoidal Antigen on a Solid Support

Linked ID
TAB-3322
Inventors
Arnold Castro (CDC)
Robert George (CDC)
Lead Inventors
Arnold Castro (CDC)
Co-Inventors
Robert George (CDC)
Development Stages
Pre-clinical (in vivo)
ICs
CDC
Commercial Applications
  • Point-of-care diagnostic testing for syphilis
  • Rapid lateral flow or flow-through combination (nontreponemal/treponemal) screening for syphilis
  • Monitoring and public health surveillance
  • Syphilis research
Competitive Advantages
  • Easy to interpret results
  • Requires no specialty equipment or refrigeration
  • Detects syphilis antibodies in serum samples
  • Combination screening and confirmatory test in one device
  • Can be used in a point-of-care assay allowing for convenience, rapid results, low costs, and field use

Request More Info

Licensing Contact